Alessandro Cavaliere

524 total citations
12 papers, 251 citations indexed

About

Alessandro Cavaliere is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Alessandro Cavaliere has authored 12 papers receiving a total of 251 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Alessandro Cavaliere's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (4 papers) and Gastric Cancer Management and Outcomes (2 papers). Alessandro Cavaliere is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (4 papers) and Gastric Cancer Management and Outcomes (2 papers). Alessandro Cavaliere collaborates with scholars based in Italy, South Korea and United States. Alessandro Cavaliere's co-authors include Davide Melisi, Michèle Milella, Raffaela Santoro, Camilla Zecchetto, Valeria Merz, Geny Piro, Serena Contarelli, Vita Fedele, Carmine Carbone and Lorena Torroni and has published in prestigious journals such as Clinical Cancer Research, International Journal of Molecular Sciences and Cancers.

In The Last Decade

Alessandro Cavaliere

11 papers receiving 250 citations

Peers

Alessandro Cavaliere
Alessandro Cavaliere
Citations per year, relative to Alessandro Cavaliere Alessandro Cavaliere (= 1×) peers Xiangbin Wan

Countries citing papers authored by Alessandro Cavaliere

Since Specialization
Citations

This map shows the geographic impact of Alessandro Cavaliere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Cavaliere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Cavaliere more than expected).

Fields of papers citing papers by Alessandro Cavaliere

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Cavaliere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Cavaliere. The network helps show where Alessandro Cavaliere may publish in the future.

Co-authorship network of co-authors of Alessandro Cavaliere

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Cavaliere. A scholar is included among the top collaborators of Alessandro Cavaliere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Cavaliere. Alessandro Cavaliere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Cavaliere, Alessandro, Monica Niger, Antonio Avallone, et al.. (2023). Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes. Cancer Chemotherapy and Pharmacology. 92(6). 501–510.
2.
Albanese, Maria, Giulia Marrone, Manuela Di Lauro, et al.. (2022). Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case–Control Study. Pharmaceuticals. 15(2). 253–253. 15 indexed citations
3.
Merz, Valeria, Camilla Zecchetto, Alessandro Cavaliere, et al.. (2021). Targeting KRAS: The Elephant in the Room of Epithelial Cancers. Frontiers in Oncology. 11. 638360–638360. 44 indexed citations
4.
Milella, Michèle, Claudio Bassi, Ugo Boggi, et al.. (2021). Evolving pancreatic cancer treatment: From diagnosis to healthcare management. Critical Reviews in Oncology/Hematology. 169. 103571–103571. 14 indexed citations
5.
Merz, Valeria, Camilla Zecchetto, Raffaela Santoro, et al.. (2020). Plasma IL8 Is a Biomarker for TAK1 Activation and Predicts Resistance to Nanoliposomal Irinotecan in Patients with Gemcitabine-Refractory Pancreatic Cancer. Clinical Cancer Research. 26(17). 4661–4669. 19 indexed citations
6.
Luchini, Claudio, Gaetano Paolino, Paola Mattiolo, et al.. (2020). KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities. Journal of Experimental & Clinical Cancer Research. 39(1). 227–227. 62 indexed citations
7.
Merz, Valeria, Alessandro Cavaliere, Carlo Messina, et al.. (2020). Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients. Cancers. 12(5). 1131–1131. 6 indexed citations
8.
Merz, Valeria, Camilla Zecchetto, Francesca Simionato, et al.. (2020). A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal–gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial. Therapeutic Advances in Medical Oncology. 12. 3863552929–3863552929. 30 indexed citations
9.
Cavaliere, Alessandro, Valeria Merz, Camilla Zecchetto, et al.. (2019). Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer. Journal of the Korean Gastric Cancer Association. 19(4). 375–375. 10 indexed citations
10.
Cascetta, Priscilla, Alessandro Cavaliere, Geny Piro, et al.. (2018). Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance. International Journal of Molecular Sciences. 19(11). 3331–3331. 40 indexed citations
11.
Carrara, Sabina, et al.. (2009). Hipertensive disorders of pregnancy. CNR Solar (Scientific Open-access Literature Archive and Repository) (Consiglio Nazionale delle Ricerche). 1 indexed citations
12.
Padula, Francesco, et al.. (2008). History of colposcopy: a brief biography of Hinselmann.. PubMed. 2(2). 19–23. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026